Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor
- 1 May 2011
- journal article
- case report
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 9 (5), 1040-1048
- https://doi.org/10.1111/j.1538-7836.2011.04245.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- GPCR monomers and oligomers: it takes all kindsTrends in Neurosciences, 2008
- Congenital disorders associated with platelet dysfunctionsThrombosis and Haemostasis, 2008
- Critical role of ADP interaction with P2Y12 receptor in the maintenance of αIIbβ3 activation: association with Rap1B activationJournal of Thrombosis and Haemostasis, 2006
- Oligomerization of the α and β isoforms of the thromboxane A2 receptor: Relevance to receptor signaling and endocytosisCellular Signalling, 2005
- SHPS‐1 negatively regulates integrin αIIbβ3 function through CD47 without disturbing FAK phosphorylationJournal of Thrombosis and Haemostasis, 2005
- Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin αIIbβ3 Activation in PlateletsPublished by Elsevier BV ,2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human PlateletsPublished by Elsevier BV ,1999
- A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.JCI Insight, 1998
- Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.JCI Insight, 1994